Croma
Saypha® Volume Lidocaine 1 ml
For licensed healthcare professionals
Shipping calculated at checkout.
Login to Order
Orders are placed through your Renellence representative. Apply for an account
- Authorized Canadian distributor
- Ships to all provinces and territories
- Clinical support from the Renellence team
Health Canada Approved (Licence #97878)
A cross-linked hyaluronic acid filler with 0.3% lidocaine for enhanced comfort. Designed for deep dermal injection to treat moderate to severe nasolabial folds .
Key Benefits
- Volumizing filler for deep wrinkles and folds
- High HA concentration (23 mg/mL) with advanced crosslinking
- Proven results up to 9 months post-treatment
- Formulated for injection into deep dermis, subcutis, or supraperiosteal tissue
- Includes 2 x 27G ½” Terumo™ needles
Indications (Canada)
saypha® volume Lidocaine is indicated for intradermal injection into the deep dermis to correct deeper wrinkles in nasolabial folds.
Product Specifications
| HA Concentration | 23 mg/mL |
| Lidocaine | 0.3% |
| Crosslinking Agent | BDDE (≤2 ppm) |
| Injection Depth | Deep dermis, subcutis, supraperiosteal |
| Syringe Volume | 1.0 mL |
| Sterilization | Steam sterilized |
Clinical Highlights
- 95% of patients showed improvement at Week 4
- 93.5% satisfaction rate at 9 months
- Designed for needle or cannula use with multiple injection techniques (fan, retrograde, bolus)
- Low extrusion force and optimal viscosity for practitioner control
*This product is intended for use by licensed healthcare professionals only. Always refer to the official IFU prior to use.
At a glance
Saypha® Volume · Correct
- Indicated for
- Moderate to severe nasolabial folds
- Injection depth
- Deep dermis, subcutis, supraperiosteal
- HA concentration
- 23 mg/mL
- Lidocaine
- 0.3%
- Results
- Up to 9 months
- Clinical highlight
- 95% improved at week 4
Health Canada licence #97878
See the treatment map →
